Niagen Bioscience (NAGE) Capital Leases (2011 - 2024)

Niagen Bioscience's (NAGE) quarterly Capital Leases came in at $2000.0 in Q3 2024, down 85.71% year-on-year from $14000.0 in Q4 2023, and down 66.67% on a QoQ basis from $6000.0 in Q2 2024.

Niagen Bioscience (NAGE) Capital Leases (2011 - 2024) Analysis & Trends

Niagen Bioscience (NAGE) has 12 years of Capital Leases data on file, last reported at $2000.0 in Q3 2024.

  • On a quarterly basis, Capital Leases fell 85.71% year-over-year to $2000.0 in Q3 2024; TTM through Sep 2024 was $2000.0, a 85.71% decrease from a year earlier, with the FY2023 full-year figure at $12000.0, down 45.45% from the prior year.
  • Capital Leases for Q3 2024 stood at $2000.0, down from $6000.0 in the prior quarter.
  • Over the last five years, Capital Leases for NAGE reached as high as $36000.0 in Q1 2020 and fell as low as $2000.0 in Q3 2024.
  • Historically, Capital Leases has averaged $16076.9 across 5 years, with a median of $14000.0 in 2023.
  • Across the five-year window, Capital Leases gained 11.11% in 2020 and slumped 85.71% in 2024, its largest moves.
  • Year by year, Capital Leases stood at $20000.0 in 2020, then slumped by 45.0% to $11000.0 in 2021, then jumped by 100.0% to $22000.0 in 2022, then sank by 45.45% to $12000.0 in 2023, then plunged by 83.33% to $2000.0 in 2024.
  • Per Business Quant data, the three most recent Capital Leases figures were $2000.0 in Q3 2024, $6000.0 in Q2 2024, and $9000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Niagen Bioscience 253.47 Mn 186.92 Mn 19.98 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 2,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 9,000.00
Dec 31, 2023 12,000.00
Sep 30, 2023 14,000.00
Jun 30, 2023 17,000.00
Mar 31, 2023 20,000.00
Dec 31, 2022 22,000.00
Sep 30, 2021 11,000.00
Jun 30, 2021 13,000.00
Dec 31, 2020 20,000.00
Jun 30, 2020 27,000.00
Mar 31, 2020 36,000.00
Dec 31, 2019 18,000.00
Sep 30, 2019 70,000.00
Jun 30, 2019 121,000.00
Mar 31, 2019 94,000.00
Dec 31, 2018 137,000.00
Sep 30, 2018 178,000.00
Jun 30, 2018 219,000.00